Metabolic control in type 2 diabetic patients treated with empagliflozin: A case series.

Wilfredo Navarrete Pilar Durruty Eileen Andrade Rodrigo Orellana María Georgina Ortiz María Angélica Budini

Published in: Medwave (2024)

Patients with type 2 diabetes mellitus with insulin requirements treated with empagliflozin at the Peñaflor Hospital achieved better glycemic control with few adverse effects.

Keyphrases

glycemic control
type diabetes
end stage renal disease
newly diagnosed
ejection fraction
blood glucose
chronic kidney disease
healthcare
prognostic factors
peritoneal dialysis
weight loss
adipose tissue
patient reported outcomes
acute care